HOME-PE trial clarifies which pulmonary embolism patients to treat at homeSeptember 1, 2020PulmonologyCardiology
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetesAugust 31, 2020CardiologyEndocrinology
EXPLORER trial hints at potential new drug option in obstructive hypertrophic cardiomyopathyAugust 30, 2020Cardiology
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effectsAugust 30, 2020CardiologyEndocrinology
